Research & Development Focus


Applying its expertise in drug discovery and early stage development, Naegis is engaged in discovering new small molecule therapeutics to treat diseases that have a significant impact on morbidity and mortality.  Inspired by chemistry found in nature, Naegis designs new molecules that regulate signaling mechanisms believed to be involved in diseases such as COPD and ocular inflammatory disorders.